$Aehr Test(AEHR)$ Aehr Test Systems (AEHR) is reporting earnings after the close, with the Street looking for around $18.7M in revenue and a return to profitability. Hitting both would be a solid sign that backlog is converting.
The last report was a rollercoaster: the stock dropped about 5% on a revenue miss, then ran from the low $50s to over $120 in roughly five weeks. Bookings had passed $92M by mid-April.
Orders have kept coming, with seven public announcements since January. That includes a couple of recent silicon photonics follow-ons, which might not even be in the backlog for this quarter.
Their role in the supply chain is pretty clear: they test optical chips at the wafer level for companies like Coherent (COHR), Lumentum (LITE), and TSMC. Catching defects early, before those chips go into systems from Broadcom (AVGO) or Nvidia (NVDA) and end up in hyperscale data centers, prevents much more expensive failures down the line.
It's an interesting setup. I'm holding through the report to see how it plays out.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
